Categories: News

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2022

WARSAW, Ind., Feb. 22, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2022. The cash dividend of $0.24 per share is payable on or about April 29, 2022 to stockholders of record as of the close of business on March 29, 2022.

About the Company

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.  

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Media                            

Investors

Meredith Weissman       

Keri Mattox

703-346-3127                

215-275-2431 

meredith.weissman@zimmerbiomet.com   

keri.mattox@zimmerbiomet.com 

Ezgi Yagci 

617-549-2443 

ezgi.yagci@zimmerbiomet.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-first-quarter-of-2022-301486659.html

SOURCE Zimmer Biomet Holdings, Inc.

Staff

Recent Posts

SeaStar Medical Holding Corporation Investors: Robbins LLP Reminds Shareholders of the SeaStar Medical Holding Corporation (ICU) Class Action

SAN DIEGO--(BUSINESS WIRE)--$ICU #ICU--Robbins LLP reminds investors that a shareholder filed a class action on…

3 hours ago

Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31

Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS),…

3 hours ago

Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut

PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo…

3 hours ago

Building telehealth equity: Insights from the Sault Ste. Marie Tribe of Chippewa Indians

New study identifies five recommendations for improving health care equity SAULT STE. MARIE, Mich., July 10, 2024…

3 hours ago

Glytec Announces Major Deals and Continued Market Leadership in Diabetes Care

Glytec Adds New Wins in 1H 2024 to Drive Inpatient Diabetes Market Momentum and Leadership…

3 hours ago

EnsoData expands sleep apnea screening and diagnosis capabilities with new acquisition

New acoustic flow and microphone channels will allow EnsoData to improve access and affordability in…

3 hours ago